Synthesis, Molecular Docking, and Peroxidase Modulatory Activity of Novel Sulphonamide-Functionalised Aspartic Acid Carboxamides

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-16

Six novel sulfonamide-functionalized aspartic acid carboxamides were synthesized and found to exhibit varying DPPH scavenging activity, with compounds 11a and 11b activating peroxidase while others inhibited it, supported by molecular docking and ADMET analyses.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-16 · read from full text

The paper reports the synthesis of six novel sulphonamide-functionalised aspartic acid carboxamide derivatives (11a–f) using benzene sulphonyl chloride and aspartic acid coupled via phenylboronic acid, followed by FTIR, 1H NMR, and 13C NMR characterization. Antioxidant activity was assessed via DPPH scavenging, with compound 11b showing an IC50 of 51.94 µg/ml and several other derivatives displaying varying activity relative to ascorbic acid. A peroxidase modulatory activity assay found that 11a and 11b activated peroxidase in a concentration-dependent manner, whereas 11c–f inhibited it, and molecular docking showed strong binding for 11a and 11b (−9.5 and −10.0 kcal/mol), with ADMET results indicating Lipinski rule-of-five compliance. The preprint does not state an explicit limitation beyond being unreviewed, and no endometriosis/adenomyosis-specific experiments are described. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Oxidative stress occurs when the production of oxygen radicals exceeds the neutralizing ability of antioxidants, triggering cellular processes such as apoptosis, tumor development, and immune system activation. In this study, six novel derivatives of aspartic acid carboxamides (11a-f) were synthesized using phenylboronic acid as a coupling agent of benzene sulphonyl chloride and aspartic acid. Biophysical characterization of the synthesized amides employed the FTIR, 1 H, and 13 C NMR spectroscopic techniques. The amide derivatives exhibited 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging property with IC 50 values of 159.96, 51.94, 99.74, 91.99, and 114.17 µg/ml for the synthesized compounds 11a, 11b, 11c, 11d, 11e, and 11f, compared to 13.38 µg/ml of ascorbic acid standard. The peroxidase modulatory activity assay showed that compounds 11a and b had the maximum peroxidase activation potential in a concentration-dependent manner. However, 11c, d, e, and f inhibited peroxidase activity. Molecular docking studies confirmed that compounds 11a and b possess high affinity with the lowest binding energy of -9.5 and − 10.0 kcal/mol, respectively. The ADMET analysis revealed that the synthesized compounds obeyed the Lipinski rule of five as potential drug candidates. Therefore, these compounds could be employed as potential drug candidates for combating oxidative stress, inflammation, and auto-oxidation of biological membranes for therapeutic intervention.
Full text 12,128 characters · extracted from preprint-html · click to expand
Synthesis, Molecular Docking, and Peroxidase Modulatory Activity of Novel Sulphonamide-Functionalised Aspartic Acid Carboxamides | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Synthesis, Molecular Docking, and Peroxidase Modulatory Activity of Novel Sulphonamide-Functionalised Aspartic Acid Carboxamides Uwem Godswill Uduak, Kingsley Nnemeka Okah, Ozoemena Emmanuel Eje, and 2 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8762707/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Oxidative stress occurs when the production of oxygen radicals exceeds the neutralizing ability of antioxidants, triggering cellular processes such as apoptosis, tumor development, and immune system activation. In this study, six novel derivatives of aspartic acid carboxamides (11a-f) were synthesized using phenylboronic acid as a coupling agent of benzene sulphonyl chloride and aspartic acid. Biophysical characterization of the synthesized amides employed the FTIR, 1 H, and 13 C NMR spectroscopic techniques. The amide derivatives exhibited 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging property with IC 50 values of 159.96, 51.94, 99.74, 91.99, and 114.17 µg/ml for the synthesized compounds 11a, 11b, 11c, 11d, 11e, and 11f, compared to 13.38 µg/ml of ascorbic acid standard. The peroxidase modulatory activity assay showed that compounds 11a and b had the maximum peroxidase activation potential in a concentration-dependent manner. However, 11c, d, e, and f inhibited peroxidase activity. Molecular docking studies confirmed that compounds 11a and b possess high affinity with the lowest binding energy of -9.5 and − 10.0 kcal/mol, respectively. The ADMET analysis revealed that the synthesized compounds obeyed the Lipinski rule of five as potential drug candidates. Therefore, these compounds could be employed as potential drug candidates for combating oxidative stress, inflammation, and auto-oxidation of biological membranes for therapeutic intervention. Drug Discovery, Design, & Development carboxamides sulphonamides peroxidase spectroscopy antioxidants molecular docking Full Text Additional Declarations The authors declare no competing interests. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8762707","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":584176478,"identity":"c8d9873c-7b1f-41c1-af5c-2f9411626a5d","order_by":0,"name":"Uwem Godswill Uduak","email":"data:image/png;base64,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","orcid":"","institution":"University of Nigeria, Nsukka","correspondingAuthor":true,"prefix":"","firstName":"Uwem","middleName":"Godswill","lastName":"Uduak","suffix":""},{"id":584179099,"identity":"fe4d30ad-e595-43f3-adae-743ebe066566","order_by":1,"name":"Kingsley Nnemeka Okah","email":"","orcid":"","institution":"University of Nigeria, Nsukka","correspondingAuthor":false,"prefix":"","firstName":"Kingsley","middleName":"Nnemeka","lastName":"Okah","suffix":""},{"id":584179100,"identity":"25a2d66c-97e8-4283-b330-5fe776cdba5c","order_by":2,"name":"Ozoemena Emmanuel Eje","email":"","orcid":"","institution":"University of Nigeria, Nsukka","correspondingAuthor":false,"prefix":"","firstName":"Ozoemena","middleName":"Emmanuel","lastName":"Eje","suffix":""},{"id":584179101,"identity":"637698af-d368-4d76-a405-f2616be3dcd8","order_by":3,"name":"Eugene Lakem Ayuk","email":"","orcid":"","institution":"Godfrey Okoye University, Enugu","correspondingAuthor":false,"prefix":"","firstName":"Eugene","middleName":"Lakem","lastName":"Ayuk","suffix":""},{"id":584179102,"identity":"17ae4a06-04dd-4cfb-8181-3e624dd3fd1d","order_by":4,"name":"Uchechukwu Chris Okoro","email":"","orcid":"","institution":"University of Nigeria, Nsukka","correspondingAuthor":false,"prefix":"","firstName":"Uchechukwu","middleName":"Chris","lastName":"Okoro","suffix":""}],"badges":[],"createdAt":"2026-02-02 09:04:58","currentVersionCode":1,"declarations":{"humanSubjects":false,"vertebrateSubjects":false,"conflictsOfInterestStatement":false,"humanSubjectEthicalGuidelines":false,"humanSubjectConsent":false,"humanSubjectClinicalTrial":false,"humanSubjectCaseReport":false,"vertebrateSubjectEthicalGuidelines":false},"doi":"10.21203/rs.3.rs-8762707/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8762707/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":101880513,"identity":"feda2c19-ef4f-44f0-a141-f77fcc310d56","added_by":"auto","created_at":"2026-02-04 15:03:06","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1146158,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript231225.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8762707/v1_covered_cf411069-c74a-47ed-ab4d-c5473db6fbc9.pdf"}],"financialInterests":"The authors declare no competing interests.","formattedTitle":"\u003cp\u003e\u003cstrong\u003eSynthesis, Molecular Docking, and Peroxidase Modulatory Activity of Novel Sulphonamide-Functionalised Aspartic Acid Carboxamides\u003c/strong\u003e\u003c/p\u003e","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"University of Nigeria","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"carboxamides, sulphonamides, peroxidase, spectroscopy, antioxidants, molecular docking","lastPublishedDoi":"10.21203/rs.3.rs-8762707/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8762707/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eOxidative stress occurs when the production of oxygen radicals exceeds the neutralizing ability of antioxidants, triggering cellular processes such as apoptosis, tumor development, and immune system activation. In this study, six novel derivatives of aspartic acid carboxamides (11a-f) were synthesized using phenylboronic acid as a coupling agent of benzene sulphonyl chloride and aspartic acid. Biophysical characterization of the synthesized amides employed the FTIR, \u003csup\u003e1\u003c/sup\u003eH, and \u003csup\u003e13\u003c/sup\u003eC NMR spectroscopic techniques. The amide derivatives exhibited 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging property with IC\u003csub\u003e50\u003c/sub\u003e values of 159.96, 51.94, 99.74, 91.99, and 114.17 \u0026micro;g/ml for the synthesized compounds 11a, 11b, 11c, 11d, 11e, and 11f, compared to 13.38 \u0026micro;g/ml of ascorbic acid standard. The peroxidase modulatory activity assay showed that compounds 11a and b had the maximum peroxidase activation potential in a concentration-dependent manner. However, 11c, d, e, and f inhibited peroxidase activity. Molecular docking studies confirmed that compounds 11a and b possess high affinity with the lowest binding energy of -9.5 and \u0026minus;\u0026thinsp;10.0 kcal/mol, respectively. The ADMET analysis revealed that the synthesized compounds obeyed the Lipinski rule of five as potential drug candidates. Therefore, these compounds could be employed as potential drug candidates for combating oxidative stress, inflammation, and auto-oxidation of biological membranes for therapeutic intervention.\u003c/p\u003e","manuscriptTitle":"Synthesis, Molecular Docking, and Peroxidase Modulatory Activity of Novel Sulphonamide-Functionalised Aspartic Acid Carboxamides","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-02-03 13:59:21","doi":"10.21203/rs.3.rs-8762707/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"534fc7d2-8b03-48ce-b7d4-d8b1811caab5","owner":[],"postedDate":"February 3rd, 2026","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":62142745,"name":"Drug Discovery, Design, \u0026 Development"}],"tags":[],"updatedAt":"2026-02-03T13:59:21+00:00","versionOfRecord":[],"versionCreatedAt":"2026-02-03 13:59:21","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8762707","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8762707","identity":"rs-8762707","version":["v1"]},"buildId":"XKTyCvWXoU3ODBz1xrDgd","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-06-05T02:00:03.366016+00:00
License: CC-BY-4.0